Work at Organizations Fighting COVID-19
With 2 million cases around the world, COVID-19 has shown the importance of pandemic preparedness. Consider joining the fight against COVID-19 and making sure something like this never happens again.
Gilead
Contribution: Researching and developing remdesivir, a potential COVID-19 vaccine currently in two Phase-3 clinical studies. Learn more here.
World Health Organization
Contribution: Supplying medical equipment, first responder trainings, public guidance, and research on COVID-19 to countries around the world. Learn more here.
Moderna
Contribution: Researching and developing mRNA-1273, a potential COVID-19 vaccine currently in Phase-1 clinical studies. Learn more here.
CEPI
Contribution: The Coalition for Epidemic Preparedness Innovations (CEPI) is currently funding and coordinating seven COVID-19 vaccine projects. Learn more here.
Novavax
Contribution: Researching and developing a potential COVID-19 vaccine based on previous experience with SARS and MERS. Expects to begin human testing by the end of spring 2020. Learn more here.
Inovio
Contribution: Researching and developing INO-4800, a DNA vaccine for COVID-19 currently in preclinical studies that is expected to to advance into Phase 1 clinical trials in the U.S. in April 2020. Learn more here.
CureVac
Contribution: Researching and developing an mRNA-based COVID-19 vaccine. Expects to begin testing a potential vaccine in people in June. Learn more here.
Medicago
Contribution: Researching and developing an mRNA-based COVID-19 vaccine. Expects to begin testing a potential vaccine in people in June. Learn more here.
Centers for Disease Control
Contribution: Educating the U.S. public about COVID-19 while leading efforts to research, diagnose and contain the disease amongst the medical community. Learn more here.
Broad Institute
Contribution: Scaling COVID-19 diagnostic testing, developing new diagnostic technologies, and generating new biological insights about COVID-19. Learn more here.
Medicago
Contribution: Developing a VLP (Virus-Like Particle) vaccine for COVID-19 currently in pre-clinical studies. Also in the early research stages for a potential antibody treatment for COVID-19. Learn more here.
Regeneron
Contribution: Researching a COVID-19 antibody treatment expected to enter human clinical studies by early summer. Also starting Phase II/III trial for a drug to treat severe COVID-19 infection. Learn more here.
Institute for Disease Modeling
Contribution: Compiling and sharing epidemiological information and disease modeling research about COVID-19. Learn more here.
Ro
Contribution: Offering a free coronavirus telehealth assessment and if appropriate, connection to a medical provider for a free consultation. Learn more here.
Everlywell
Contribution: Developing 30,000+ at-home collection kits with telehealth diagnoses for COVID-19. Learn more here.
Johnson & Johnson
Contribution: Researching a potential COVID-19 vaccine, with plans for clinical trials in November 2020. Learn more here.
Altimmune
Contribution: Researching and developing a single-dose, intranasal vaccine to protect against COVID-19, with plans for clinical trials in August 2020. Learn more here.
Sanofi
Contribution: Researching and developing a treatment currently in Phase II/III trials for severe COVID-19 coronavirus infection. Learn more here.
IDSA
Contribution: A community of infectious disease experts currently researching and raising awareness of COVID-19. Learn more here.
Verily
Contribution: Releasing a free online risk screening and testing program for COVID-19, initially limited to the California Bay Area. Learn more here.
Adaptive Biotech
Contribution: Working with Amgen to research the best human antibodies that neutralize SARS-CoV-2 and potentially other related coronaviruses Learn more here.
Amgen
Contribution: Working with Adaptive to research the best human antibodies that neutralize SARS-CoV-2 and potentially other related coronaviruses Learn more here.
GigaGen
Contribution: Researching an antibody therapy for the treatment of COVID-19 with the goal of starting clinical trials in early 2021 (pending FDA approval). Learn more here.
One Medical
Contribution: Offering free COVID-19 testing in more than 9 cities and 30 days of free virtual care to anyone with COVID-19 concerns. Learn more here.
Celularity
Contribution: Received FDA clearance to investigate how placental cells might be a source of immune defense therapy against COVID-19. Learn more here.
BillionToOne
Contribution: Developing a novel COVID-19 test that has more than 30x higher throughput than existing testing methods and is highly accurate and cost-effective. Learn more here.
No time to keep track of relevant postings at all these companies? Download Dolphin and get proactive recommendations.
Are we missing an organization? Suggest it below.